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tion and intensive care unit (ICU) organization 
processes often make this approach difficult to 
adopt. In recent years, many tools for bedside 
assessment of pain, sedation and delirium have 
been proposed, and their systematic application 
in clinical practice seems to offer a relevant 
benefit.2-4 By contrast, few high level clinical 
trials have evaluated the efficacy of pharmaco-
logical and non-pharmacological strategies for 
PAD treatment. For instance, although current-
The management of pain, agitation and de-lirium (PAD) is still a challenge in criti-
cally ill patients. Clinical studies have demon-
strated that a protocolized and evidence based 
approach to PAD is cost-effective and can sig-
nificantly improve patient outcomes.1 Never-
theless, factors related to pre-existing patients’ 
conditions, type and degree of organ dysfunc-
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BACKGROUND: The management of analgesia and sedation in critically ill patients is still a challenge due to the short-
age of evidence-based treatments. The main objectives of the present study were to critically evaluate the quality of cur-
rent clinical practice guidelines (CPGL) published on this matter and to identify the contrasting positions and unsolved 
questions.
METhODS: Four members of the Italian Society of Anesthesia and Intensive Care (SIAARTI) council, with an extensive 
background in the management of critically ill patients and practice guidelines, evaluated CPGL on sedation and anal-
gesia in critically ill patients published from January 2006 to December 2013. Evaluation was performed in accordance 
with the appraisal of guidelines for research and evaluation tool (AGREE II).
RESULTS: Five documents proposed by European and American scientific societies of critical care medicine were identi-
fied and evaluated. The CPGL published in 2013 by the American Society of Critical Care Medicine showed the highest 
scores in all domains of the AGREE II tool, whereas scores for CPGL published in 2006 by SIAARTI showed the lowest 
scores. In all documents, most recommendations on the use of drugs or non-pharmacological strategies for analgesia, 
sedation and delirium treatment had low evidence.
CONCLUSIONS: This quality evaluation indicated that CPGLs published by the German Association of Scientific Medi-
cal Societies, the American College of Critical Care Medicine and the PanAmerican and Iberica Federation of the Critical 
Care Medicine Societies should be recommended for use. Even in guidelines with a high quality rating, numerous recom-
mendations have moderate or low levels of evidence. 
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of development, clarity and presentation, ap-
plicability and editorial independence. Each 
of the AGREE II items are rated on a 7-point 
scale (1–strongly disagree; 7–strongly agree). 
Domain scores are calculated by adding to-
gheter all the scores of the individual items in 
a domain, and by scaling the total as a percent-
age of the maximum possible score for that 
domain.10 In addition, the AGREE II tool also 
includes an overall assessment of the guide-
line and whether it should be strongly recom-
mended, recommended with provisos, or not 
recommended.
Assessments were performed independently 
by the four members using a specific electronic 
database with accompanying explanatory notes. 
To determine whether errors may have occurred 
during item scoring, one investigator (GM) ex-
amined all final item scores across the 4 apprais-
als. Discrepancies were defined as inter-rate 
score differences of three points on any domain 
item. All appraisers were then asked to perform 
another AGREE II assessment on the discord-
ant item in question. For each selected CPGL, 
the median scores for the various domains were 
calculated and compared among the CPGLs 
using the Kruskal-Wallis Test. Analysis was 
performed using SPSS version 20 (SPSS Inc., 
Chicago, IL, USA) and P<0.05 was considered 
statistically significant.
Results
Clinical practice guideline selection and char-
acteristics
The databases analysis provided 5 CPGL on 
PAD management in critically ill adult patients 
published from January 2006 to December 
2013. Throughout the years, the methodolo-
gies for developing CPGL have changed from 
the Delphi method to the Grading of Recom-
mendations, Assessment, Development and 
Evaluation (GRADE) method.12, 13 The topics 
included were quite similar, except for deliri-
um identification and management that were 
discussed extensively only in the more recent 
CPGLs. Specific indications for particular pop-
ulations (e.g. elderly, trauma and burns) were 
ly recommended by recent guidelines,1, 5 the 
use of quetiapine and of re-orientation strate-
gies for the prevention and management of de-
lirium is based on low-quality studies.6
Due to these aforementioned considerations, 
the use of clinical practice guidelines (CPGL) 
based on the best available evidence is essen-
tial for supporting the decision-making pro-
cess in  PAD management. In the last decade, 
numerous CPGL documents on this issue have 
been published worldwide by several scientific 
societies of critical care medicine. As for other 
publications, a CPGL ought to be critically ap-
praised prior to endorsing its use, because poor 
quality guidelines may contribute to inappro-
priate recommendations and low adherence.7-9 
The appraisal of guidelines, research and eval-
uation (AGREE) tool has been developed and 
validated as an useful instrument to assess the 
methodological rigour and transparency with 
which a guideline has been developed.10, 11 The 
aim of our study, supported by the Italian So-
ciety of Anaesthesia and Intensive Care Medi-
cine (SIAARTI), was to assess the quality of 
the published guidelines on PAD management 
using the AGREE II tool.
Materials and methods
Four members of the SIAARTI council, with 
an extensive background in the management 
of critically ill patients and CPGL methodol-
ogy, were involved in the quality assessment. 
CPGL documents were selected by searching 
the Medline (PubMed), Scopus and Intercol-
legiate Studies Institute Web of Knowledge 
databases from 2006 to 2013. Relevant da-
tabases of guidelines including the National 
Guideline Clearing House, National Institute 
for Healthcare Excellence, Scottish Intercol-
legiate Guidelines Network and the National 
Guideline System were also searched. We re-
stricted our search to the adult population.
For the quality assessment of CPGL, the 
appraisal of guidelines, research and evalu-
ation (AGREE) tool has been developed and 
validated.10 AGREE II evaluation includes 
23 items subdivided within 6 domains: scope 
and purpose, stakeholder involvement, rigor 
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90.5%) (Figure 1). In all the CPGLs evalu-
ated, the applicability domain achieved the 
lowest quality scores, whereas the scope and 
purpose domain achieved the highest quality 
scores.
The CPGLs by SIAARTI and by the French 
Society of Anesthesia and Intensive Care and 
the French Society of Intensive Care Medi-
cine (SFAR-SRLF) 15, 16 had the lowest scores 
(P<0.05) compared to other CPGLs for 3 do-
mains (scope and purpose, stakeholder in-
volvement and applicability) and in the overall 
assessment. The evaluators recommended the 
use of the CPGLs by AWMF, the Pan-Ameri-
can and Iberica Federation of the Critical Care 
Medicine Societies and the American College 
of Critical Care Medicine (ACCM).1, 5, 14 The 
last CPGL showed the highest overall quality 
score (Figure 1).
Discussion
In our quality evaluation, the three CPGLs 
on PAD management in critically ill patients 
provided by the German Association of Scien-
tific Medical Societies, the American College 
included for all documents. The CPGL by the 
German Association of Scientific Medical So-
cieties (AWMF) 14 also included indications 
for pregnant, lactating and moribund patients, 
while those by Pan-American and Iberica Fed-
eration of the Critical Care Medicine Societies 5 
provided indications for patients with renal and 
liver failure. The number of statements and rec-
ommendations ranged from 6 in the CPGL by 
the Italian Society of Anesthesia and Intensive 
Care (SIAARTI) 15 to 137 in those by the Pan-
American and Iberica Federation of the Critical 
Care Medicine Societies.5 An executive sum-
mary was provided in only 2 documents 1, 14 
and the strength of the majority of the recom-
mendations was strong (or very strong) with 
moderate or low evidence (Table I).1, 5, 14-16
Appraisal of guidelines by the AGREE II in-
strument
Agreement among reviewers for the 5 doc-
uments was high (>80%). The median qual-
ity scores for the six domains and the overall 
assessment were 78.6, 58.7, 72.6, 69.8, 41.7, 
57.1 and 66.7% respectively (range 33.3-
Table I.—Year of publication, target population, main areas, layout, and summary of the recommendations of the 
evaluated documents.
Reference Year Targetpopulation Main areas Layout
Summary of 
recommendations
Italian Society of 
Anesthesia and 
Intensive Care 15
2006 Adults with specific 
populations
Monitoring (pain, sedation); drugs 
(analgesia, sedation, withdrawal); 
specific population
30 pages with 6 
tables
1 high level + 4 low level + 
1 very low level; total 6
French Society of 
Anesthesia and 
Intensive Care and 
the French Society 
of Intensive Care 
Medicine 16
2008 Adults with specific 
populations and 
children
Definition and goals (pain, sedation); 
drugs and other methods; monitoring 
(pain, sedation, delirium); sedation 
withdrawn; practical issues
11 pages with 4 
tables
8 without strength and 
evidence
German Association 
of Scientific Medical 
Societies 14




Monitoring (pain, sedation, delirium); 
treatment (pain, sedation, delirium); 
economy, quality, implementation; 
specific populations
39 pages with 
24 figures and 
tables
56 very strong; 30 strong; 
27 weak; total 123
American College of 
Critical Care Medicine 1
2013 Adults with specific 
populations
Pshycometric scales; analgesics; 
pain (incidence, monitoring, 
treatment); agitation and sedation 
(depth, monitoring, drugs); delirium 
(outcomes, monitoring, risk factors, 
prevention, treatment); practical 
issues
43 pages with 
8 tables and 3 
figures




of the Critical Care 
Medicine Societies 5
2013 Adults with specific 
populations
Indications patient oriented; 
monitoring (sedation, analgesia, 
delirium); treatment (delirium, 
withdrawal)
55 pages with 
14 tables and 7 
figures
114 strong, 23 weak; total 
137
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SFAR-SRLF AWMF ACCM Pan-American
Figure 1.—Fraction of the maximal score of the six domains 
and the overall assessment for the clinical practice guidelines 
(CPGL) evaluation by the AGREE II tool. X-axis: CPGL; y-
axis: fraction of maximal score. SIAARTI: Italian Society of 
Anesthesia and Intensive Care; SFAR-SRLF: French Soci-
ety of Anesthesia and Intensive Care and the French Society 
of Intensive Care Medicine; AWMF: German Association of 
Scientific Medical Societies; ACCM: American College of 
Critical Care Medicine; Pan-American: Pan-American and 
Iberica Federation of the Critical Care Medicine Societies.
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contrast with the others, the CPGL by the Pan-
American and the Iberica Federation of the 
Critical Care Medicine Societies strongly rec-
ommend the use of low dose remifentanil con-
tinuous infusion for analgesia and sedation in 
patients undergoing weaning from mechanical 
ventilation despite the low level of evidence.5 
Moreover, although the evidence from litera-
ture was the same, the recommendations for 
the use of antipsychotic drugs in the manage-
ment of delirium are clearly different between 
the CPGLs by the ACCM and the Pan-Ameri-
can and Iberica Federation of the Critical Care 
Medicine Societies.1, 5 The shortage of high 
level studies for many of the items included 
in the CPGLs poses questions on the reliabil-
ity of these recommendations, and their effects 
remain uncertain and may vary in different pa-
tients, contexts and organizations.
Conclusions
Our quality evaluation provides useful in-
dications for the appropriate use of available 
CPGLs on PAD management. Considering 
the possible legal implications of guidelines 
produced by national professional bodies and 
accepted as “the standard to be achieved”, old 
and low-quality level documents should be 
discarded in favor of the more recent and high-
quality level ones. Unfortunately, the adop-
tion of CPGLs developed in different regions 
may be difficult due to possible differences in 
availability of resources and in clinical behav-
ior. Therefore, an urgent revision and updat-
ing of the SIAARTI and SFAR-SRLF docu-
ments 15, 16 is highly recommended. Moreover, 
our study advises different CPGL developers 
to integrate the GRADE approach, used for 
grading the quality of evidence and strength 
of recommendations, with the suggestions by 
the AGREE II Collaboration when preparing 
future guidelines on PAD, with particular fo-
cus on stakeholder involvement and methods 
for its implementation in clinical practice. Last 
but not least, as for many other issues in criti-
cally ill patients, there is an urgent need for 
large and appropriate clinical studies on anal-
gosedation and delirium treatment.
of Critical Care Medicine and the Pan-Ameri-
can and Iberica Federation of the Critical Care 
Medicine Societies revealed high overall as-
sessment scores and, thereby, are recommended 
for use.1, 5,14 To our knowledge, this is the first 
systematic evaluation of the quality of CPGLs 
for the management of PAD.
The highly scored CPGLs adequately coped 
with the majority of domains included in the 
AGREE II tool. Indeed, applicability and 
stakeholder involvement were the domains 
that performed most poorly. Compliance in 
clinical practice to the recommendations of a 
CPGL is still difficult and the reasons are wide-
ranging. Among these, difficulty in CPGL dis-
semination and implementation play a pivotal 
role. Therefore, a CPGL should include a clear 
description of facilitators and barriers to its 
application, tools on how recommendations 
can be put into practice, and the potential re-
source implications. Unfortunately, as report-
ed in other CPGL quality evaluations,7, 17 these 
items were not or only partially included in the 
CPGLs on PAD management.
The scarce involvement of stakeholders in 
the development of a CPGL may further hin-
der its implementation in clinical practice. In 
the AGREE II tool, the domain on the stake-
holders’ involvement explores whether the 
CPGL represents the views of its intended us-
ers. Involving stakeholders is recognized as 
an important part of producing credible, rigor-
ous, and transparent CPGLs.18 A review of the 
NICE guideline program by the World Health 
Organization stated that “collaboration with 
stakeholders in the development of the guide-
lines through the consultation and feedback 
mechanisms available was in general very ef-
fective”.19
It is important to note that the AGREE II 
tool has been developed to assess the method-
ological quality of a guideline, but it does not 
evaluate the clinical content and the quality 
of the evidence supporting the recommenda-
tions.11 In fact, our CPGLs appraisal outlined 
common criticisms related to the low level of 
evidence for the majority of the strong rec-
ommendations, particularly on analgesia and 
delirium management.1, 5, 14 For instance, in 
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algesia in critically ill adult patients. Med Intensiva 2013; 
37:519-74.
 6. Reade MC, Finfer S. Sedation and delirium in the inten-
sive care unit. N Engl J Med 2014;370:444-54.
 7. Sinuff T, Patel RV, Adhikari NK, Meade MO, Schüne-
mann HJ, Cook DJ. Quality of professional society 
guidelines and consensus conference statements in criti-
cal care. Crit Care Med 2008;36:1049-58.
 8. Eldh AC, Vogel G, Söderberg A, Blomqvist H, Weng-
ström Y. Use of evidence in clinical guidelines and 
everyday practice for mechanical ventilation in Swed-
ish intensive care units. Worldviews Evid Based Nurs 
2013;10:198-207.
 9. Pun BT, Balas MC, Davidson J. Implementing the 2013 
PAD guidelines: top ten points to consider. Semin Respir 
Crit Care Med 2013;34:223-35.
10. Brouwers MC, Kho ME, Browman GP, Burgers JS, 
Cluzeau F, Feder G, et al. AGREE II: advancing guide-
line development, reporting, and evaluation in health 
care. Prev Med 2010;51:421-4.
11. AGREE Collaboration. Development and validation of 
an international appraisal instrument for assessing the 
quality of clinical practice guidelines: the AGREE pro-
ject. Qual Saf Health Care 2003;12:18-23.
12. Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh 
AA, Ernst A, et al. An official ATS statement: grading the 
quality of evidence and strength of recommendations in 
ATS guidelines and recommendations. Am J Respir Crit 
Care Med 2006;174:605-14.
13. Guyatt G, Gutterman D, Baumann Mh, Addrizzo-harris 
D, Hylek EM, Phillips B, et al. Grading strength of rec-
ommendations and quality of evidence in clinical guide-
lines: report from an american college of chest physicians 
task force. Chest 2006;129:174-81.
14. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bür-
kle H, et al. Evidence and consensus-based German guide-
lines for the management of analgesia, sedation and delir-
ium in intensive care--short version. Ger Med Sci 2010;8: 
Doc02.
15. Mattia C, Savoia G, Paoletti F, Piazza O, Albanese D, 
Amantea B, et al. SIAARTI recommendations for anal-
go-sedation in intensive care unit. Minerva Anestesiol 
2006;72:769-805.
16. Sauder P, Andreoletti M, Cambonie G, Capellier G, Feis-
sel M, Gall O,Goldran-Toledano D, et al. Sedation and 
analgesia in intensive care (with the exception of new-
born babies). French Society of Anesthesia and Resus-
citation. French speaking Resuscitation Society. Ann Fr 
Anesth Reanim 2008;27:541-51.
17. Gorman SK, Chung MH, Slavik RS, Zed PJ, Wilbur K, 
Dhingra VK. A critical appraisal of the quality of criti-
cal care pharmacotherapy clinical practice guidelines and 
their strength of recommendations. Intensive Care Med 
2010;36:1636-43.
18. Kastner M, Bhattacharyya O, Hayden L, Makarski J, Es-
tey E, Durocher L, et al. Guideline uptake is influenced 
by six implementability domains for creating and com-
municating guidelines: a realist review. J Clin Epidemiol 
2015;10: S0895-4356.
19. National Institute for Health and Clinical Excellence The 
guideline development process: an overview for stake-
holders, the public and the NHS. Third edition; 2007.
Key messages
 — A protocolized and evidence based 
approach to pain, analgesia and delirium 
management is cost-effective and can sig-
nificantly improve the patient outcomes.
 — The use of clinical practice guide-
lines is essential for supporting the deci-
sion-making process, and numerous docu-
ments on pain, analgesia and delirium 
management have been published in the 
last decade.
 — The recent guidelines by the Ger-
man Association of Scientific Medical 
Societies, the American College of Criti-
cal Care Medicine and the Pan-American 
and Iberica Federation of the Critical Care 
Medicine Societies are recommended for 
use.
 — The shortage of high level studies 
poses some questions on the true effects 
of  guideline recommendations on pain, 
analgesia and delirium management. High 
quality clinical trials on this issue are ur-
gently needed.
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